References
- Varadarajan P, Kapoor N, Bansal RC, et al. Survival in elderly patients with severe aortic stenosis is dramatically improved by aortic valve replacement: results from a cohort of 277 patients aged > or = 80 years. Eur J Cardiothorac Surg 2006;30:722-7
- Hulstaert F, Neyt M, Vinck I, et al. Pre-market clinical evaluations of innovative high-risk medical devices in Europe. Int J Technol Assess Health Care (accepted for publication) 2012;28:278-84
- Smith CR, Leon MB, Mack MJ, et al. Transcatheter versus surgical aortic-valve replacement in high-risk patients. N Engl J Med 2011;364:2187-98
- Leon MB, Smith CR, Mack M, et al. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med 2010;363:1597-607
- Hancock-Howard R, Feindel C, Rodes-Cabau J, et al. Transfemoral aortic valve replacement versus medical management in high risk patients with symptomatic aortic valve stenosis: Canadian cost-effectivenessanalysis based on the PARTNER trial cohort B findings. J Med Econ; 16. (Published Online February 6, 2013.)
- Neyt M, Van Brabandt H, Van de Sande S, et al. Transcatheter Aortic Valve Implantation (TAVI): a health technology assessment update. KCE Reports. Brussels: Belgian Health Care Knowledge Centre (KCE), 2011
- Van Brabandt H, Neyt M, Hulstaert F. Transcatheter aortic valve implantation (TAVI): risky and costly. BMJ 2012;345:e4710
- FDA. SAPIEN® THV Briefing Document – Advisory Committee Meeting. FDA, 2011. p 301. Available at http://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/MedicalDevices/MedicalDevicesAdvisoryCommittee/CirculatorySystemDevicesPanel/UCM262935.pdf. [Last accessed 12 February 2013].
- Makkar RR, Fontana GP, Jilaihawi H, et al. Transcatheter aortic-valve replacement for inoperable severe aortic stenosis. N Engl J Med 2012;preprint1696-704
- FDA. FDA Executive summary: Edwards SAPIEN THV. FDA, 2011. Available at http://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/MedicalDevices/MedicalDevicesAdvisoryCommittee/CirculatorySystemDevicesPanel/UCM262930.pdf. [Last accessed 12 February 2013].
- Blackman D, PCR LondonValves, editor. UK TAVI Registry. Outcome of TAVI by valve type and access route. London, 2011. Available at http://www.pcronline.com/Lectures/2011/Outcome-of-TAVI-by-valve-type-and-access-route.-UK-TAVI-registry. [Last accessed 12 February 2013]
- Gilard M. FRANCE II - FRench Aortic National CoreValve and Edwards registry. EuroPCR2011. Paris, 2011
- Thuesen L. A prospective, randomized trial of transapical transcatheter aortic valve implantation vs. surgical aortic valve replacement in operable elderly patients with aortic stenosis. The STACCATO Trial. TCT congress 2011 November 10, 2011; San Francisco, CA
- Van Brabandt H, Neyt M. Percutaneous heart valve implantation in congenital and degenerative valve disease. A rapid Health Technology Assessment. KCE Reports. Brussels: Belgian Health Care Knowledge Centre (KCE), 2008
- NICE. Transcatheter aortic valve implantation for aortic stenosis. NICE interventional procedure guidance 421. London: NICE, 2012
- Alli OO, Booker JD, Lennon RJ, et al. Transcatheter aortic valve implantation: assessing the learning curve. JACC Cardiovasc Interv 2012;5:72-9
- Neyt M, Van Brabandt H, Devriese S, et al. A cost-utility analysis of transcatheter aortic valve implantation in Belgium: focusing on a well-defined and identifiable population. BMJ Open 2012;2:1-8. DOI: 10.1136/bmjopen-2012-001032
- Mohr F. The German aortic valve registry. 40th Annual Meeting of the German Society for Thoracic and Cardiovascular Surgery; 2011; Stuttgart